Table 2.
Logistic regression analysis for factors associated with prevalence of cardiovascular disease, cirrhosis, chronic kidney disease and Type II diabetes mellitus by BMI categorya
| BMI category | Any cardiovascular disease | Coronary artery disease | Peripheral artery disease | Cerebrovascular accident | Congestive heart failure | Cirrhosis | Chronic Kidney Disease stage ≥ 3 | Type II DM | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR (95 % CI)a |
p value | OR (95 % CI) |
p value | OR (95 % CI) |
p value | OR (95 % CI) |
p value | OR (95 % CI) |
p value | OR (95 % CI) |
p value | OR (95 % CI) | p Value | OR (95 % CI)b | p Value | ||
| Lean | Referent | Referent | Referent | Referent | Referent | Referent | Referent | Referent | |||||||||
| Overweight | 0.88 (0.80–0.97) | <0.01 | 0.88 (0.80–0.97) | <0.01 | 0.82 (0.74–0.91) | <0.01 | 0.69 (0.61–0.76) | <0.01 | 0.74 (0.67–0.83) | <0.01 | 1.22 (1.01–1.47) | <0.01 | 0.96 (0.86–1.08) | 0.53 | 0.86 (0.79–0.93) | <0.01 | |
| Obesity class I | 0.86 (0.79–0.95) | <0.01 | 0.86 (0.79–0.95) | <0.01 | 0.72 (0.65–0.80) | <0.01 | 0.61 (0.55–0.68) | <0.01 | 0.75 (0.67–0.83) | <0.01 | 1.35 (1.12–1.63) | <0.01 | 1.06 (0.94–1.18) | 0.35 | 1.17 (1.09–1.27) | <0.01 | |
| Obesity class II – III | 0.86 (0.78–0.94) | <0.01 | 0.86 (0.78–0.94) | <0.01 | 0.63 (0.57–0.70) | <0.01 | 0.52 (0.55–0.68) | <0.01 | 1.14 (1.03–1.26) | 0.01 | 1.58 (1.31–1.89) | <0.01 | 1.17 (1.05–1.30) | <0.01 | 1.95 (1.81–2.10) | <0.01 | |
| Non-Lean * | 0.87 (0.81–0.94) | <0.01 | 0.87 (0.80–0.94) | <0.01 | 0.72 (0.65–0.79) | <0.01 | 0.60 (0.54–0.66) | <0.01 | 0.89 (0.81–0.98) | 0.02 | 1.40 (1.17–1.67) | <0.01 | 1.07 (0.96–1.18) | 0.22 | 1.32 (1.23–1.42) | <0.01 | |
Abbreviations: CI, confidence interval; OR, odds ratio.
OR adjusted for age, sex, race, smoking status, hypertension, dyslipidemia, DM, and aspirin and statin use.
For Type II DM, OR was adjusted with the same confounders excluding DM
non-lean analysis was performed using a different model